Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

M Röpke, J Hald, Per Guldberg, J Zeuthen, L Nørgaard, L Fugger, A Svejgaard, S Van der Burg, H W Nijman, C J Melief, Mogens Helweg Claesson

145 Citations (Scopus)

Abstract

A cytotoxic T lymphocyte (CTL) clone generated in vitro from the peripheral blood of a healthy HLA-A2-positive individual against a synthetic p53 protein-derived wild-type peptide (L9V) was shown to kill squamous carcinoma cell lines derived from two head and neck carcinomas, which expressed mutant p53 genes, in a L9V/HLA-A2 specific and restricted fashion. Thus, the normal tolerance against endogenously processed p53 protein-derived self-epitopes can be broken by peptide-specific in vitro priming. p53 protein-derived wild-type peptides might thus represent tumor associated target molecules for immunotherapeutical approaches.
Original languageEnglish
JournalProceedings of the National Academy of Sciences of the United States of America
Volume93
Issue number25
Pages (from-to)14704-7
Number of pages4
ISSN0027-8424
Publication statusPublished - 10 Dec 1996

Keywords

  • Carcinoma, Squamous Cell
  • Cytotoxicity, Immunologic
  • HLA-A2 Antigen
  • Head and Neck Neoplasms
  • Humans
  • Mutation
  • T-Lymphocytes, Cytotoxic
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53

Fingerprint

Dive into the research topics of 'Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide'. Together they form a unique fingerprint.

Cite this